Industry News
Family risk of breast cancer does not affect psychosocial adjustment among pre-teen girls
10/20/2015
Girls from families with a history of breast cancer, or genetic mutations that increase the risk of a breast cancer diagnosis, seem to adjust just as well as other girls when it comes to general...
Nivolumab in melanoma: Added benefit in certain patients
10/20/2015
Survival advantage for treatment-naive patients with BRAF V600 wt tumor / no evaluable data available for other patient groupsNivolumab (trade name: Opdivo) has been approved since June 2015 for...
Stored blood transfusion 'safe' after heart surgery
10/20/2015
Despite previous conflicting studies, new research finds that use of stored blood for transfusions after heart surgery is safe and does not influence patient outcomes.
A new way to starve lung cancer?
10/20/2015
Metabolic alterations in lung cancer may open new avenues for treating the diseaseScientists have identified a new way to stop the growth of lung cancer cells, by blocking their ability to use...
UGR scientists patent an effective drug for treating breast, colon, and skin cancers
10/20/2015
Reduced the tumor activity by 50 percent following 41 days of treatmentScientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in...
Family risk of breast cancer does not affect psychosocial adjustment among pre-teen girls
10/20/2015
Girls from families with a history of breast cancer, or genetic mutations that increase the risk of a breast cancer diagnosis, seem to adjust just as well as other girls when it comes to general...
Annual vs. biennial mammography and breast tumor prognostic characteristics
10/20/2015
Premenopausal women diagnosed with breast cancer following a biennial screening mammogram were more likely to have bigger more advanced tumors than women screened annually, while postmenopausal...
Although some studies have suggested that transfusion of stored red blood cell (RBC) concentrates may be harmful, as blood undergoes several physiological changes during storage, an analysis of...
Nivolumab in melanoma: Added benefit in certain patients
10/20/2015
Survival advantage for treatment-naive patients with BRAF V600 wt tumor / no evaluable data available for other patient groupsNivolumab (trade name: Opdivo) has been approved since June 2015 for...
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.